Treating dermatophytosis among children

Comparison Of Oral Terbinafine Alone And Oral Terbinafine With Fluconazole in Dermatophytosis Among Children

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230428058014N1

Enrollment

200

Registered

2023-05-26

Start date

2023-05-22

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatophytosis- fungal infection. Dermatophytosis

Interventions

Intervention 1: 1. Intervention group A: in Group A the patients are treated with Terbinafine orally at following doses:62.5 mg/day for 20kg body weight. Intervention 2: Intervention group B: In Group

Eligibility

Sex/Gender

All

Age

1 Months to 18 Years

Inclusion criteria

Inclusion criteria: clinical diagnosis of tinea corporis, tinea cruris or tinea faciei, Tinea pedis, tinea capitis microscopic confirmation (potassium hydroxide [KOH] microscopy) age birth to 18 years no treatment with terbinafine or fluconazole in last one month.

Exclusion criteria

Exclusion criteria: presence of any other type(s) of tinea, e.g., onychomycosis, inability to come for follow-up, history of adverse reaction to terbinafine and/or fluconazole, history of renal, liver or cardiac disease

Design outcomes

Primary

Measure	Time frame
Clinical Response based on clearance of lesions. Timepoint: 4 weeks , 8 weeks. Method of measurement: Clinical response evaluation.	—

Countries

Pakistan

Contacts

Public ContactAmmara Hameed

PNS Shifa Hospital, Karachi

ammarahameed@hotmail.com+92 333 3416393

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026